Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To explore a possible role of
acylphosphatase
in the regulation of energy metabolism, we measured this enzyme's activity and content in skeletal muscle, liver and erythrocytes of normal and tri-iodothyronine treated rabbits. Besides
acylphosphatase
we assayed (Na+ + K+)-ATPase, Ca2(+)-ATPase and several enzymes of carbohydrate metabolism. Acylphosphatase activity in erythrocytes rose steadily during treatment with triiodothyronine (25 micrograms/Kg per day for 5 weeks), and its increase occurred earlier and was much more pronounced than that of other soluble enzymes. In erythrocytes of treated animals (Na+ + K+)-ATPase declined whereas Ca2(+)-ATPase activity increased, in agreement with previously reported findings. In muscle and liver of the treated animals
acylphosphatase
activity was about twice as high as in the controls; in these tissues we found also increased activities for (Na+ + K+)-ATPase, fructose-1,6-bisphosphatase and
glucose-6-phosphatase
. In any case, among the enzymes we examined,
acylphosphatase
was one of the most strongly and regularly stimulated by the treatment. Furthermore we observed, through an immunochemical procedure, that there was a congruence between increases in
acylphosphatase
activity and content. On the basis of these results we conclude that the rise in
acylphosphatase
levels in treated animals is probably due to its increased biosynthesis. The possible significance of these findings in the metabolic modifications associated with hyperthyroidism are discussed.
...
PMID:Increased acylphosphatase levels in erythrocytes, muscle and liver of tri-iodothyronine treated rabbits. 215 65